An evolving scientific basis for the prevention and treatment of pediatric obesity

P T Katzmarzyk1, S Barlow2, C Bouchard1

  • 1Pennington Biomedical Research Center, Baton Rouge, LA, USA.

Insights

Pediatric obesity presents a significant global health challenge. This review highlights advances in prevention, treatment, and management, emphasizing genetic and environmental factors, and clinical interventions.

Area of Science:

  • Pediatrics
  • Public Health
  • Genetics
  • Endocrinology

Background:

  • Pediatric obesity is a complex, growing public health concern with long-term health implications.
  • Understanding the multifactorial nature of pediatric obesity is crucial for effective intervention.
  • The 2013 Pennington Biomedical Research Center's Scientific Symposium addressed critical aspects of pediatric obesity.

Purpose of the Study:

  • To review scientific advances in pediatric obesity prevention, treatment, and management.
  • To integrate the latest findings into clinical and public health strategies.
  • To provide recommendations for evidence-based practice in pediatric obesity care.

Main Methods:

  • The symposium convened experts to discuss current research and clinical practices.
  • Presentations covered genetic, epigenetic, and maternal factors influencing offspring adiposity.
  • Discussions included behavioral interventions, pharmacotherapy, and bariatric surgery for pediatric populations.

Main Results:

  • New scientific insights into the developmental programming of adiposity were presented.
  • The role of maternal pre-pregnancy obesity, nutrition, and weight gain was examined.
  • Evidence for various behavioral, pharmacological, and surgical treatments was evaluated.

Conclusions:

  • Pediatric obesity is an unprecedented challenge threatening public health gains.
  • Integrating scientific evidence into clinical and public health approaches is essential.
  • Multifaceted strategies addressing genetic and environmental factors are needed for effective management.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368